Table: Modalis Therapeutics - 6-MTH group results

Modalis Therapeutics

07/08/2023 07:00

Aug 7 (Reuters)- 
             Modalis Therapeutics Corporation 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Jun 30, 2023        Jun 30, 2022     Dec 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales                                40 mln                     
                (-100.0 pct)                                      
  Operating       loss 1.04         loss 868 mln                  
  Recurring     loss 995 mln        loss 780 mln                  
  Net             loss 1.03         loss 775 mln                  
  EPS          loss 34.70 yen      loss 26.70 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL              NIL     
  
  NOTE - Modalis Therapeutics Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T